Location: United States
Investors 1
| Date | Name | Website |
| - | Apple Tree... | appletreep... |
Mentions in press and media 3
| Date | Title | Description |
| 21.04.2025 | Aethon Therapeutics to Share Preclinical and Discovery-Stage Updates on KRAS-G12C Hapten-Peptide Immunotherapies at AACR 2025 | New York, April 21, 2025 — Aethon Therapeutics, Inc., a biotechnology company discovering and developing novel antibody therapeutics designed to attack cancer cells in tandem with targeted covalent inhibitor cancer therapies, will present u... |
| 04.04.2024 | Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs | Aethon will apply its proprietary HapImmune™ platform to create novel antibodies that home in on cancer neoantigens generated by treatment with RAS inhibitors Collaboration focuses on key Revolution Medicines pipeline programs NEW YORK, Apr... |
| - | Aethon Therapeutics | - |